Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: gemcitabine and cisplatin
Sponsor: Fudan University